Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Smartphone-based Optical Blood Spectrum Imaging (TOI) in Evaluating Renal Function Damage in Hypertensive Emergency Patients

NCT06201572 is registered in ClinicalTrials.gov with The Affiliated Hospital of Hangzhou Normal University as lead sponsor.

NCT NCT06201572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06201572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Smartphone-based Optical Blood Spectrum Imaging (TOI) in Evaluating Renal Function Damage in Hypertensive Emergency Patients
Lead sponsor
The Affiliated Hospital of Hangzhou Normal University
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2024
Completion date
December 31, 2024
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertensive emergency